Not reduced genome sequencing capacity, says govt

Genome sequencing capacity has not been reduced in the country, and since its inception, the INSACOG has sequenced 58,240 SARS-CoV-2 genomes, the Parliament was informed.
Out of these, 46,124 samples have been analysed, assigned pangolin lineage classification and submitted to the National Centre for Disease Control (NCDC) for public health correlation, the Lok Sabha was informed through a written reply.

The capacity has enhanced by expanding INSACOG network from 10 laboratories to 28 laboratories, and efforts in terms of expansion of INSACOG by onboarding more laboratories have been undertaken.

The Indian SARS-CoV-2 Genomics Consortium, or the INSACOG, is the consortium of 28 genome sequencing laboratories of the Department of Biotechnology, the Department of Science and Technology, the Health and Family Welfare Ministry, the Council of Scientific and Industrial Research (CSIR), the Education Ministry, the Indian Council of Medical Research (ICMR) and state governments. It was established as an inter-ministerial initiative with an overall objective to expand whole genome sequencing of SARS-CoV-2 virus across the nation, and aiding understanding of how the virus spreads and evolves.

The specific objectives of INSACOG are to ascertain the current status of new variant of SARS-CoV-2 in the country; establish a sentinel surveillance for early detection of genomic variants with public health implication; determine the genomic variants in the unusual events/trends (super-spreader events, high mortality/morbidity trend areas etc.), a statement said.

Standard Operating Procedures (SOPs) have been developed to accelerate the pace of genome sequencing in terms of the number of samples to be sequenced as well as the time for reporting and undertake sequencing of samples from hospitals and for sewerage surveillance as a public health tool to understand Covid-19 spread in a community. These initiatives provide significant scientific information to assist and guide the public health decisions for Covid-19 management in the country, it added.-IANS